CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
期刊信息导读
- CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS基本信息
- CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS中科院SCI期刊分区
- 历年CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS影响因子趋势图
- CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS期刊英文简介
- CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS期刊中文简介
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS基本信息
简称:CRIT REV THER DRUG
中文名称:治疗药物载体系统的评论
SCI类别:SCI/SCIE
是否OA开放访问:No
出版地:UNITED STATES
出版周期:Bimonthly
创刊年份:1984
涉及的研究方向:医学-药学
通讯方式:BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896
官方网站:http://dl.begellhouse.com/journals/3667c4ae6e8fd136.html
投稿网址:http://submission.begellhouse.com/usr/login.html?prod_code=journals
审稿速度:>12周,或约稿
平均录用比例:较易
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0743-4863%5BISSN%5D
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS期刊英文简介
The Journal invites for review original papers dealing with interactions of chemicals with biological systems. All aspects of pharmacology and therapeutics are appropriate, but descriptive case reports without dose-response or mechanistic studies are not acceptable. Manuscripts dealing primarily with new methods will be reviewed only if data are presented showing that new or more reliable pharmacological information has been obtained with their use.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS期刊中文简介
该杂志邀请评论关于化学物质与生物系统相互作用的原始论文。药理学和治疗学的所有方面都是适当的,但是没有剂量反应或机制研究的描述性病例报告是不能接受的。只有在提供数据表明使用新方法获得了新的或更可靠的药理信息时,才会审查主要涉及新方法的手稿。
中科院SCI期刊分区:
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS影响因子